We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cost-effectiveness of 24 or 48 weeks of interferon alpha-2b alone or with ribavirin as initial treatment of chronic hepatitis C. International Hepatitis Interventional Therapy Group.
- Authors
Wong, J B; Poynard, T; Ling, M H; Albrecht, J K; Pauker, S G
- Abstract
Initial therapy with ribavirin and interferon alpha-2b results in a higher sustained virological response than interferon alone, but this regimen is expensive. We aimed to examine the cost-effectiveness of 24- or 48-wk initial treatment with combination therapy versus interferon alone for patients who have chronic hepatitis C.
- Publication
The American journal of gastroenterology, 2000, Vol 95, Issue 6, p1524
- ISSN
0002-9270
- Publication type
Journal Article
- DOI
10.1111/j.1572-0241.2000.2089_1.x